A61P 5 - Drugs for disorders of the endocrine system

Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
11/2002
11/05/2002	US6476195 Secreted protein HNFGF20
11/05/2002	US6476079 Devices for the delivery of drugs having antiprogestinic properties
11/05/2002	US6476026 Compounds and compositions as protease inhibitors
11/05/2002	US6476010 Orally administering to a post-menopausal woman a fat soluble vitamin and a fat soluble vitamin absorption increasing effective amount of l-carnitine or salts
11/05/2002	US6475532 Calcium channel antagonist possessing an inhibitory action against secretion of parathyroid hormones and a use thereof
11/05/2002	US6475493 Controlled release pellet formulation
11/05/2002	US6475468 Modulated release particles for aerosol delivery
10/2002
10/31/2002	WO2002086107A2 A method for differentiating stem cells into insulin-producing cells
10/31/2002	WO2002086069A2 Secreted proteins
10/31/2002	WO2002085925A2 Melanocortin receptor ligands
10/31/2002	WO2002085921A2 Simple method for the synthesis of boswellic acids and derivatives thereof
10/31/2002	WO2002085907A1 Novel 3-c(o)r substituted 10-cyclohexylbenzoyl pyrrolobenzodiazepines; tocolytic oxytocin receptor antagonists
10/31/2002	WO2002085899A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002	WO2002085891A1 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
10/31/2002	WO2002085851A1 Pyrrole derivative
10/31/2002	WO2002085447A2 Microprojection array having a beneficial agent containing coating
10/31/2002	WO2002085376A2 A method for decreasing superoxide anion production and for the treatment of diseases associated with oxidative stress
10/31/2002	WO2002085375A1 Novel hormone composition
10/31/2002	WO2002085354A1 Spiroindene and spiroindane compounds
10/31/2002	WO2002085336A1 Orodispersible effervescent tablets
10/31/2002	WO2002085330A1 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
10/31/2002	WO2002043750A3 Method for the stabilizing of biomolecules (e.g. insulin) in liquid formulations
10/31/2002	WO2002036105A3 Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders
10/31/2002	WO2002022611A3 Caspase inhibitors and uses thereof
10/31/2002	WO2001058855A9 Use of androgen receptor suppressors
10/31/2002	WO2001044243A3 Novel heteroaryl-diazabicycloalkanes
10/31/2002	WO2000062766A3 Uses of ppar-gamma agonists in neutrophil-induced diseases
10/31/2002	US20020160997 Novel indole derivatives
10/31/2002	US20020160961 Thyrotropin-Releasing Hormone (TRH) and a peptide of given formula, such as ipamorelin; treatment of wasting
10/31/2002	US20020160955 Protein variants
10/31/2002	US20020160938 At least one is a human or animal insulin analogue; coupled together with a diacid such as by reacting with suberic acid, bis(N-hydroxysuccinimidyl) ester
10/31/2002	US20020160494 Tendon-inducing compositions
10/31/2002	US20020160109 Microencapsulation of drugs by solvent exchange
10/31/2002	DE10121217A1 6H-Oxazolo[4,5-e]indol-Derivate als nikotinische Acetylcholinrezeptor Liganden und/oder serotonerge Liganden 6H-oxazolo [4,5-e] indole derivatives as nicotinic acetylcholine receptor ligands and / or serotonergic ligands
10/31/2002	DE10121215A1 Dihydro-imidazo[4,5-e]indol- und 7H-Pyrrolo[3,2-f]chinoxalin Derivate als nikotinische Acetylcholinrezeptor Liganden und/oder serotonerge Liganden Dihydro-imidazo [4,5-e] indole and 7H-pyrrolo [3,2-f] quinoxaline derivatives as nicotinic acetylcholine receptor ligands and / or serotonergic ligands
10/31/2002	DE10118452A1 Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse Nucleic acid sequences of hyperplasias and tumors of the thyroid
10/31/2002	CA2444883A1 Microprojection array having a beneficial agent containing coating
10/31/2002	CA2444675A1 Secreted proteins
10/31/2002	CA2444599A1 Melanocortin receptor ligands
10/31/2002	CA2443600A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002	CA2443556A1 Novel 3-c(o)r substituted 10-cyclohexylbenzoyl pyrrolobenzodiazepines; tocolytic oxytocin receptor antagonists
10/30/2002	EP1252333A2 Methods and materials relating to cd84-like polypeptides and polynucleotides
10/30/2002	EP1252150A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
10/30/2002	EP1251855A1 Selective estrogen receptor modulators in combination with estrogens
10/30/2002	EP1251829A1 Electrospun pharmaceutical compositions
10/30/2002	CN1377424A Methods of reparing tandemly repeated DNA sequences and extending cell life-span using nuclear transfer
10/30/2002	CN1377371A Parathyroid hormone analogues for the treatment of osteoporosis
10/30/2002	CN1377356A Certain alkylene diamine-substituted heterocycles
10/30/2002	CN1377346A Z-pyrazoline-5-ones
10/30/2002	CN1377259A ACE-2 inhibiting compounds and methods of use thereof
10/29/2002	US6472531 Single reaction vessel acylation and deetherification production of crystalline, high purity chemical intermediates for such as pharmaceuticals
10/29/2002	US6472505 Treatment of physiological conditions capable of being modulated by agonist or antagonist activity on parathyroid hormone receptors
10/29/2002	US6472415 Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
10/29/2002	EP1144613A4 Methods for making proteins containing free cysteine residues
10/29/2002	CA2156493C Method of preventing or inhibiting fertilization
10/25/2002	CA2383175A1 Methods and kits for treating depression or preventing deterioration of cognitive function
10/24/2002	WO2002083936A2 Novel method for screening inhibitors of the linkage between the neuronal nitric oxide synthase associated protein and the protein inhibiting neuronal nitric oxide synthase
10/24/2002	WO2002083734A2 Modified calcitonin
10/24/2002	WO2002083727A2 Nucleic acid sequences of hyperplasies and tumors of the thyroid
10/24/2002	WO2002083685A1 Cyclohexylphenyl vasopressin agonists
10/24/2002	WO2002083684A1 Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepi ne-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083683A1 Novel tricyclic pyridyl benzazepine carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083682A1 Novel 10-cyclohexenyl-phenyl pyrrolobenzodiazepine-3-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083681A1 Novel cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
10/24/2002	WO2002083679A1 Novel hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083668A1 Isoxaxole derivatives as inhibitors of src and other protein kinases
10/24/2002	WO2002083667A2 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/24/2002	WO2002083666A1 Substituted benzofuran-2-carboxamides derivatives
10/24/2002	WO2002083643A1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
10/24/2002	WO2002083241A1 Single dose aromatase inhibitor for treating infertility
10/24/2002	WO2002083240A1 Aromatase inhibition to enhance assisted reproduction
10/24/2002	WO2002083239A1 Aromatase inhibitors for treating infertility
10/24/2002	WO2002083186A1 Nuclear receptor-mediated introduction of a pna into cell nuclei
10/24/2002	WO2002083146A1 Multiple dose aromatase inhibitor for treating infertility
10/24/2002	WO2002083145A1 N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists
10/24/2002	WO2002083134A1 Aryl and biaryl piperidines used as mch antagonists
10/24/2002	WO2002083128A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method
10/24/2002	WO2002083115A1 Treatment of disorders secondary to organic impairments
10/24/2002	WO2002083107A1 Adhesive emulsion for medical purposes made from ethylene-vinyl acetate copolymers and adhesive resins
10/24/2002	WO2002066078A3 Modulated release particles for aerosol delivery
10/24/2002	WO2002066077A3 Modulated release particles for aerosol delivery
10/24/2002	WO2002057226A9 68730 and 69112 protein kinase molecules and uses therefor
10/24/2002	WO2002050065A3 Pyrazole compounds useful as protein kinase inhibitors
10/24/2002	WO2002040038A3 M. tuberculosis chaperonin 10 and uses thereof
10/24/2002	WO2001068676A3 Lhrh-antagonists, production and use thereof as medicament
10/24/2002	US20020156234 Obtaining insulin precursors; generate suspension of insulin and cysteine hydrochloride, heat, recover insulin precursors
10/24/2002	US20020156089 Use of CRF antagonists and related compositions
10/24/2002	US20020156081 Pyrazolopyrimidines as therapeutic agents
10/24/2002	US20020156024 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
10/24/2002	US20020155598 Generating insulin secreting cells; obtain mammalian pancreatic tissues, dissociate cells, dedifferentiate into insulin precursor cells, isolate and propagate cells
10/24/2002	US20020155597 In vivo production and delivery of erthropoietin or insulinotropin for gene therapy
10/24/2002	US20020155539 Calcium channel polynucleotides, polypeptides, and antibodies
10/24/2002	US20020155144 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
10/24/2002	US20020155100 Compositions and methods for regulated protein expression in gut
10/24/2002	DE10119905A1 Enriching intermediates in the mevalonate-independent pathway of isoprenoid synthesis, useful for therapeutic activation of T cells, comprises altering enzymatic activity in the pathway
10/24/2002	CA2445029A1 Novel method for screening inhibitors of the linkage between the neuronal nitric oxide synthase associated protein and the protein inhibiting neuronal nitric oxide synthase
10/24/2002	CA2444932A1 Aromatase inhibition to enhance assisted reproduction
10/24/2002	CA2444465A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method
10/24/2002	CA2444455A1 N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists
10/24/2002	CA2443870A1 Cyclohexylphenyl vasopressin agonists

1 ... 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 ... 290